JAMES B. BREITMEYER - Chief Executive Officer, Director at Oncternal Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
ONCT
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by JAMES B. BREITMEYER since 09 Mar 2025

Holdings reported by JAMES B. BREITMEYER for Oncternal Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 443,034 $219,789 $0.4961 03 Jan 2024 Direct
Common Stock 196,544 $97,505 $0.4961 03 Jan 2024 By Family Trust
Common Stock 15,426 $7,653 $0.4961 03 Jan 2024 By Spouse
Common Stock 733 $364 $0.4961 03 Jan 2024 By Child
Stock Option 28,400 14 Feb 2024 Direct Common Stock
Stock Option 6,200 14 Feb 2024 By Spouse Common Stock

Transactions reported by JAMES B. BREITMEYER for Oncternal Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.